drugset / Trial / NCT00667992

Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma

NCT00667992

Phase 3 Completed 99 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

This study is being carried out to see if budesonide with HFA is effective, safe and well tolerated compared with budesonide CFC. Budesonide HFA has been already given in other research studies, in both healthy volunteers and subjects with asthma.

Timeline

Start
2008-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 100 ug Inhaled
Comparator Budesonide Small molecule 400 ug Inhaled

Indications